The Complete (but Practical) Guide to Phenytoin Dosing

Today is the day we tackle phenytoin. I want you pumped and ready to take it down. Because it’s a beast even more beastly than the roguish wampa of vancomycin.

Clinical, Pharmacy School, PracticeBrandon DysonMay 26, 2017phenytoin, gingival hyperplasia, phenytoin dosing, how to dose phenytoin, phenytoin dosing guide, phenytoin dose adjustments, zero order kinetics, pharmacokinetics, phenytoin pharmacokinetics

New FDA Approval: Ingrezza

Drug

Valbenazine [Ingrezza]

Indication

The treatment of adults with tardive dyskinesia.

Clinical, FDA Approval, Pharmacy School, PracticeBrandon DysonMay 5, 2017valbenazine, ingrezza, ingrezza cost, valbenazine cost, tardive dyskinesia, antipsychotic, first generation antipsychotic, second generation antipsychotic, vmat2 inhibitor, fda approval

Hypercalcemia: An Overview for Pharmacists

Electrolyte disorders is a subject that usually gets filed in the dreaded "learn and dump" part of your brain.

You know that place? Your own personal island of misfit toys where information goes to be forgotten

Clinical, Pharmacy School, PracticeBrandon DysonApril 21, 2017hypercalcemia, hypercalcemia of malignancy, pamidronate, bisphosphonates, RANKL, RANK, denosumab, zoledronic acid, calcium metabolism, calcium, electrolyte, electrolyte disorders, calcitonin

How to Be Awesome at Biostatistics and Literature Evaluation - Part II

This post explores the more applied concepts such as odds, risk, hazards, and correlation. These concepts are the heart of inferential statistics because they represent different ways of comparing one thing to another

New FDA Approval: Parsabiv

Drug

Etelcalcitide [Parsabiv]

Indication

The treatment of secondary hyperparathyroidism in adults on dialysis.

Clinical, FDA Approval, Pharmacy School, PracticeBrandon DysonFebruary 13, 2017hyperparathyroidism, PTH, parathyroid gland, etelcalcitide, Parsabiv, secondary hyperparathyroidism, calcimimetic, phosphate binder, osteoclast, bone resorption, calcium metabolism, sensipar, cinacalcet

How to Be Awesome at Biostatistics and Literature Evaluation - Part I

As with all things tl;dr pharmacy, this post will (ironically) be stupendously long. But it will serve as your one stop shop for all things biostats and clinical literature related.

Clinical, Pharmacy School, PracticeBrandon DysonFebruary 6, 2017biostats, biostatistics, literature evaluation, p-value, clinical significance, type i error, type II error, null hypothesis, alternative hypothesis, confidence interval, standard deviation, mean, median, mode, normal distribution

New FDA Approval: Vemlidy

Drug

Tenofovir alafenamide [Vemlidy]

Indication

The treatment of adults with chronic hepatitis B virus (HBV) with compensated liver disease

Clinical, FDA Approval, Pharmacy School, PracticeBrandon DysonJanuary 12, 2017Vemlidy, Tenofovir Alafenamide, tenofovir, HBV, Hepatitis B, HIV drugs cheat sheet, Viread

New FDA Approval: Zinplava

Drug

Bezlotoxumab [Zinplava]

Indication

To reduce the recurrence of Clostridium difficile infection (CDI) in patients 18 years old and over.

FDA Approval, Clinical, Pharmacy School, PracticeBrandon DysonDecember 4, 2016zinplava place in therapy, zinplava, bezlotoxumab, bezlotoxumab place in therapy, zinplava adverse effects, bezlotoxumab adverse effects

How to Study for the Pharmacy Curriculum Outcomes Assessment (PCOA)

There's a new acronym on the rise in pharmacy education. One that's striking fear in the hearts of students everywhere.

PCOA

The Pharmacy Curriculum Outcomes Assessment.

Pharmacy School, Residency, Clinical, ProfessionalBrandon DysonNovember 20, 2016pharmacy curriculum outcomes assessment, PCOA, How to study for the PCOA, How to study for PCOA, What is the PCOA, What to do if you fail the PCOA, PCOA Pharmacy, PCOA Test, What is the PCOA pharmacy test

Heart Failure Part 3: Pharmacotherapy

Ok, so now onto pharmacotherapy - updated for the 2022 Guidelines!

Last time we talked about signs and symptoms and discussed the Frank-Starling curve. We are going to talk about the agents used in HF and how they affect this curve.

Clinical, Residency, PracticeBrandon DysonNovember 12, 2016heart failure, systolic heart failure, diastolic heart failure, HFpEF, HFrEF, HF, CHF, Clinical Pearls, congestive heart failure, cardiovascular, digoxin

Pain Management: The tl;dr Pharmacy Guide

Opioid abuse comes in many forms; and it's not just the stereotypical junkie that's doctor shopping and trying to refill their Norco 2 weeks early "because the cops stole them." Opioid abuse can also show up in more insidious ways.....

Clinical, Pharmacy School, PracticeSamuel OhOctober 13, 2016Clinical Pearls, Pain, Pharmacotherapy, COX-2, NSAIDs, Opioids, Tramadol, Pain Management, Neuropathy, Nociception, opioid conversions, opioid clinical pearls, opioid cheat sheet, pain management, pain management cheat sheet

New FDA Approval: Amjevita

Drug

Adalimumab-atto [Amjevita]

Indication

Amjevita is a biosimilar to adalimumab [Humira], so it has the same indications. It's used in inflammatory conditions mediated by the immune system

FDA Approval, Clinical, Pharmacy School, PracticeBrandon DysonOctober 10, 2016Amjevita, adalimumab, biosimilar, amjevita place in therapy, adalimumab place in therapy